Lidocaine toxicity in the setting of HeartMate II left ventricular assist device.

Published in: Journal of clinical pharmacy and therapeutics (2018)

This case highlights the potential for marked deviation from published pharmacokinetic parameters for a narrow therapeutic window agent with concurrent LVAD.

Keyphrases

left ventricular assist device
oxidative stress
locally advanced
human health
randomized controlled trial
risk assessment
rectal cancer
oxide nanoparticles